Another term is adiposity-based chronic disease, which focuses on adverse health outcomes that a person might be at risk for or develop from having excess weight
[academic.oup.com] Showed favorable changes in lipidomics and metabolomics profiles
The problem, it seems, is that catalase and other antioxidant defenses may decline as we age, and leave melanocytes vulnerable to their own hot-potato production of pigment
And the results of that trial were published last August (2017): Title: Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial Authors: Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T Journal: Lancet 2017 Aug 3
They are based in San Po Kong, Hong Kong